We used synthetic peptides to the extracellular loops (ECLs) of CCR5 to examine inhibitory effects on HIV infection/fusion with primary leukocytes and cells expressing recombinant CCR5. We show for the first time that peptides derived from the first, second, or third ECL caused dose-dependent inhibition of fusion and infection, although with varying potencies and specificities for envelope glycoproteins (Envs) from different strains. The first and third ECL peptides inhibited Envs from the R5 Ba-L strain and the R5X4 89.6 strain, whereas the second ECL peptide inhibited Ba-L but not 89.6 Env. None of the peptides affected fusion mediated by Env from the X4 LAV strain.
IntroductionInfection by HIV-1 requires surface expression of 2 specific receptors on the target cell: CD4 (the primary receptor) and a specific chemokine receptor (the coreceptor). In the generally accepted model for HIV-1 entry (for reviews, see Wyatt and Sodroski 1 and Eckert and Kim 2 ), the external glycoprotein (gp) 120 subunit of the HIV-1 envelope glycoprotein (Env) initiates infection through specific binding to the first domain of CD4. The CD4 interaction induces a conformational change that exposes a highly conserved coreceptor binding site on gp120, which, along with variable loops on gp120, enables gp120 to bind to the coreceptor. The gp120-coreceptor interaction then triggers conformational changes in the gp41 transmembrane subunit of Env, presumably leading to exposure of the N-terminal fusion peptide and its insertion into the plasma membrane of the target cell to initiate the membrane fusion process.Individual HIV-1 isolates can display markedly distinct phenotypes for infection of different CD4-expressing cell types such as primary macrophages, transformed T-cell lines, or primary T cells. Target cell tropism is determined primarily by the ability of the corresponding Env to interact with one or both of the major coreceptors (CCR5, CXCR4), coupled with the expression patterns of these receptor molecules on the different target cell types (for a review, see Berger et al 3 ). HIV-1 isolates capable of using CCR5 but not CXCR4 (designated R5) 4-8 are typically macrophage tropic and greatly predominate after acute infection and throughout the asymptomatic phase. Isolates able to use CXCR4 9 are first detected during the transition to the symptomatic phase; those that function with CXCR4 but not CCR5 (designated X4) are typically T-cell line tropic, whereas those able to function with both coreceptors (designated R5X4) are dual tropic. All these HIV-1 phenotypes readily infected activated primary CD4 ϩ T cells. The gp120/ corecptor interaction has become a major focus for the development of new anti-HIV agents for treating or preventing HIV-1 infection (for reviews, see Agrawal and Alkhatib 10 and Biscone et al 11 ).The coreceptors are members of the superfamily of G-proteincoupled receptors (GPCRs). These proteins are characterized by 7 transmembrane segments that form a helical bundle, an extracellular region that includes the N-ter...